Skip to content
10-Q

Quarterly Report

LEMAITRE VASCULAR INC LMAT

0001193125-26-207500

← back to feed
Filed
May 6, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 4, 2026 22.85M sh
Shares Diluted Q1 2026 · Mar 31, 2026 23.03M sh
Shares Diluted Q1 2026 · Mar 31, 2025 22.9M sh
Stock Repurchased Q1 2026 · Mar 31, 2026 $460K
Stock Repurchased Q1 2026 · Mar 31, 2025 $601K
Dividends Paid Q1 2026 · Mar 31, 2026 $5.71M
Dividends Paid Q1 2026 · Mar 31, 2025 $4.52M
Operating Cash Flow Q1 2026 · Mar 31, 2026 $15.09M
Operating Cash Flow Q1 2026 · Mar 31, 2025 $9.04M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $26.85M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $28.24M
Stockholders Equity Q1 2026 · Mar 31, 2026 $406.62M
Stockholders Equity Q1 2026 · Dec 31, 2025 $393.52M
Stockholders Equity Q1 2026 · Mar 31, 2025 $347.57M
Stockholders Equity Q1 2026 · Dec 31, 2024 $337.29M
Current Liabilities Q1 2026 · Mar 31, 2026 $33.37M
Current Liabilities Q1 2026 · Dec 31, 2025 $36.32M
Total Liabilities Q1 2026 · Mar 31, 2026 $222.9M
Total Liabilities Q1 2026 · Dec 31, 2025 $222.17M
Current Assets Q1 2026 · Mar 31, 2026 $477.82M
Current Assets Q1 2026 · Dec 31, 2025 $468.23M
Total Assets Q1 2026 · Mar 31, 2026 $629.53M
Total Assets Q1 2026 · Dec 31, 2025 $615.69M
Eps Diluted Q1 2026 · Mar 31, 2026 $0.68
Eps Diluted Q1 2026 · Mar 31, 2025 $0.48
Eps Basic Q1 2026 · Mar 31, 2026 $0.69
Eps Basic Q1 2026 · Mar 31, 2025 $0.49
Sga Expense Q1 2026 · Mar 31, 2026 $12.05M
Sga Expense Q1 2026 · Mar 31, 2025 $10.49M
Rd Expense Q1 2026 · Mar 31, 2026 $4.06M
Rd Expense Q1 2026 · Mar 31, 2025 $4.1M
Net Income Q1 2026 · Mar 31, 2026 $15.68M
Net Income Q1 2026 · Mar 31, 2025 $11.01M
Operating Income Q1 2026 · Mar 31, 2026 $17.78M
Operating Income Q1 2026 · Mar 31, 2025 $12.63M
Gross Profit Q1 2026 · Mar 31, 2026 $48.4M
Gross Profit Q1 2026 · Mar 31, 2025 $41.42M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $18.16M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $18.45M